Report cover image

Japan Neurology Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Value Chain – Market Forecast, 2025–2034

Published Sep 01, 2025
Length 124 Pages
SKU # PLRS20451534

Description

The Japan neurology clinical trials market size is expected to reach USD 856.27 million by 2034, according to a new study by Polaris Market Research. The report “Japan Neurology Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Value Chain – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Japan neurology clinical trials market involves the research and development of new drugs, therapies, and medical devices designed to treat conditions of the nervous system. This includes a wide range of diseases and disorders affecting the brain, spinal cord, and peripheral nerves, such as Alzheimer's, Parkinson's, epilepsy, and stroke.

Japan is home to world-class universities, hospitals, and research centers specializing in neurological sciences. Institutions such as the University of Tokyo, Kyoto University, and RIKEN have extensive expertise in brain research and clinical trial execution. These centers often collaborate with pharmaceutical companies on large-scale studies targeting complex conditions such as ALS, epilepsy, and dementia. The availability of specialized neurology departments, skilled investigators, and advanced diagnostic tools improves the quality and efficiency of clinical trials, making Japan a highly attractive destination for neurology research and development, thereby driving the market growth.

Japan has one of the world’s fastest-aging populations. This demographic trend significantly increases the prevalence of age-related neurological diseases such as Alzheimer’s, Parkinson’s, and stroke. The growing number of elderly patients is putting pressure on Japan’s healthcare system, creating a strong demand for innovative treatments. Consequently, pharmaceutical companies and research institutions are actively conducting clinical trials to develop effective therapies, thereby driving the growth.

Japan Neurology Clinical Trials Market Report Highlights:

The phase III segment accounted for the largest share in 2024, driven by Japan’s strong focus on confirming the safety and efficacy of neurological treatments before regulatory approval.

The observational studies segment is projected to witness the fastest growth during the forecast period, fueled by the rising demand for real-world evidence to better understand the progression and impact of neurological disorders.

A few key players in the market include IQVIA, ICON plc, Syneos Health, Laboratory Corporation of America Holdings, Charles River Laboratories, Thermo Fisher Scientific, Parexel, Medpace Holdings, and pharmaceutical companies like Pfizer, Biogen, and Eisai Co.

Polaris Market Research has segmented the Japan neurology clinical trials market report based on phase, study design, indication, and value chain:

By Phase Outlook (Revenue – USD Million, 2020–2034)

Phase I

Phase II

Phase III

Phase IV

By Study Design Outlook (Revenue – USD Million, 2020–2034)

Interventional

Observational

Expanded Access

By Indication Outlook (Revenue – USD Million, 2020–2034)

Alzheimer’s Disease

Depression (MDD)

Parkinson's Disease (PD)

Epilepsy

Stroke

Traumatic Brain Injury (TBI)

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Muscle Regeneration

Others

By Value Chain Outlook (Revenue – USD Million, 2020–2034)

In-house

CROs

Investigator Sites/Clinical Sites

Table of Contents

124 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Middle East Carbon Dioxide (CO₂) Market Insights
4.1. Carbon Dioxide (CO₂) Market – Market Snapshot
4.2. Carbon Dioxide (CO₂) Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Expanding Beverage Industry
4.2.1.2. Growing Urbanization
4.2.2. Restraints and Challenges
4.2.2.1. High Energy Consumption in Capturing and Storing CO2
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Carbon Dioxide (CO₂) Market Trends
4.6. Value Chain Analysis
5. Middle East Carbon Dioxide (CO₂) Market, by Source
5.1. Key Findings
5.2. Introduction
5.2.1. Middle East Carbon Dioxide (CO₂) Market, by Source, 2020-2034 (USD Billion, Volume Kiloton)
5.3. Hydrogen
5.3.1. Middle East Carbon Dioxide (CO₂) Market, by Hydrogen, by Region, 2020-2034 (USD Billion, Volume Kiloton)
5.4. Ethyl Alcohol
5.4.1. Middle East Carbon Dioxide (CO₂) Market, by Ethyl Alcohol, by Region, 2020-2034 (USD Billion, Volume Kiloton)
5.5. Ethylene Oxide
5.5.1. Middle East Carbon Dioxide (CO₂) Market, by Ethylene Oxide, by Region, 2020-2034 (USD Billion, Volume Kiloton)
5.6. Substitute Natural Gas
5.6.1. Middle East Carbon Dioxide (CO₂) Market, by Substitute Natural Gas, by Region, 2020-2034 (USD Billion, Volume Kiloton)
5.7. Others
5.7.1. Middle East Carbon Dioxide (CO₂) Market, by Others, by Region, 2020-2034 (USD Billion, Volume Kiloton)
6. Middle East Carbon Dioxide (CO₂) Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Middle East Carbon Dioxide (CO₂) Market, by Application, 2020-2034 (USD Billion, Volume Kiloton)
6.3. Food & Beverages
6.3.1. Middle East Carbon Dioxide (CO₂) Market, by Food & Beverages, by Region, 2020-2034 (USD Billion, Volume Kiloton)
6.4. Oil & Gas
6.4.1. Middle East Carbon Dioxide (CO₂) Market, by Oil & Gas, by Region, 2020-2034 (USD Billion, Volume Kiloton)
6.5. Medical
6.5.1. Middle East Carbon Dioxide (CO₂) Market, by Medical, by Region, 2020-2034 (USD Billion, Volume Kiloton)
6.6. Rubber
6.6.1. Middle East Carbon Dioxide (CO₂) Market, by Rubber, by Region, 2020-2034 (USD Billion, Volume Kiloton)
6.7. Firefighting
6.7.1. Middle East Carbon Dioxide (CO₂) Market, by Firefighting, by Region, 2020-2034 (USD Billion, Volume Kiloton)
6.8. Others
6.8.1. Middle East Carbon Dioxide (CO₂) Market, by Others, by Region, 2020-2034 (USD Billion, Volume Kiloton)
7. Middle East Carbon Dioxide (CO₂) Market, by Geography
7.1. Key Findings
7.2. Introduction
7.2.1. Carbon Dioxide (CO₂) Market Assessment, By Geography, 2020-2034 (USD Billion, Volume Kiloton)
7.3. Carbon Dioxide (CO₂) Market – Middle East
7.3.1. Middle East & Africa: Carbon Dioxide (CO₂) Market, by Source, 2020-2034 (USD Billion, Volume Kiloton)
7.3.2. Middle East & Africa: Carbon Dioxide (CO₂) Market, by Application, 2020-2034 (USD Billion, Volume Kiloton)
7.3.3. Carbon Dioxide (CO₂) Market – Saudi Arabia
7.3.3.1. Saudi Arabia: Carbon Dioxide (CO₂) Market, by Source, 2020-2034 (USD Billion, Volume Kiloton)
7.3.3.2. Saudi Arabia: Carbon Dioxide (CO₂) Market, by Application, 2020-2034 (USD Billion, Volume Kiloton)
7.3.4. Carbon Dioxide (CO₂) Market – UAE
7.3.4.1. UAE: Carbon Dioxide (CO₂) Market, by Source, 2020-2034 (USD Billion, Volume Kiloton)
7.3.4.2. UAE: Carbon Dioxide (CO₂) Market, by Application, 2020-2034 (USD Billion, Volume Kiloton)
7.3.5. Carbon Dioxide (CO₂) Market – Qatar
7.3.5.1. Israel: Carbon Dioxide (CO₂) Market, by Source, 2020-2034 (USD Billion, Volume Kiloton)
7.3.5.2. Israel: Carbon Dioxide (CO₂) Market, by Application, 2020-2034 (USD Billion, Volume Kiloton)
7.3.6. Carbon Dioxide (CO₂) Market – Israel
7.3.6.1. Israel: Carbon Dioxide (CO₂) Market, by Source, 2020-2034 (USD Billion, Volume Kiloton)
7.3.6.2. Israel: Carbon Dioxide (CO₂) Market, by Application, 2020-2034 (USD Billion, Volume Kiloton)
7.3.7. Carbon Dioxide (CO₂) Market – Rest of Middle East
7.3.7.1. Rest of Middle East & Africa: Carbon Dioxide (CO₂) Market, by Source, 2020-2034 (USD Billion, Volume Kiloton)
7.3.7.2. Rest of Middle East & Africa: Carbon Dioxide (CO₂) Market, by Application, 2020-2034 (USD Billion, Volume Kiloton)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. Air Liquide
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. Air Products and Chemicals, Inc.
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. ADNOC
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Aramco
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. EIG
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development
9.6. Gulf Cryo
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Development
9.7. Linde PLC
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Development
9.8. SABIC
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Development
9.9. SICGIL Industrial Gases Ltd
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Development
9.10. Technip Energies
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.